Free Trial

Amrize Ltd (NYSE:AMRZ) Short Interest Update

Amrize logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest rose 14.3% in April to 6,787,840 shares (about 1.2% of the float), giving a short-interest ratio of 3.1 days based on average daily volume.
  • Insiders and institutions are accumulating: CEO Jan Philipp Jenisch bought 60,000 shares at about $58.05 and insiders bought 77,834 shares this quarter, while large investors including Vanguard, Norges Bank and Harris Associates built sizable positions.
  • Analyst view and recent results: the consensus rating is "Moderate Buy" with a $64.07 target; Amrize missed Q1 EPS by $0.02 (‑$0.16 vs. ‑$0.14) and declared a $0.11 dividend payable May 20.
  • MarketBeat previews the top five stocks to own by June 1st.

Amrize Ltd (NYSE:AMRZ - Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totaling 6,787,840 shares, an increase of 14.3% from the March 31st total of 5,938,933 shares. Currently, 1.2% of the shares of the stock are sold short. Based on an average daily volume of 2,181,267 shares, the short-interest ratio is presently 3.1 days.

Insiders Place Their Bets

In related news, insider Mario Gross purchased 3,200 shares of the stock in a transaction that occurred on Friday, March 13th. The stock was acquired at an average price of $55.29 per share, with a total value of $176,928.00. Following the completion of the acquisition, the insider directly owned 30,947 shares in the company, valued at approximately $1,711,059.63. This trade represents a 11.53% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jan Philipp Jenisch purchased 60,000 shares of the stock in a transaction that occurred on Friday, March 6th. The stock was bought at an average cost of $58.05 per share, with a total value of $3,483,000.00. Following the acquisition, the chief executive officer owned 1,703,582 shares of the company's stock, valued at $98,892,935.10. This represents a 3.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 77,834 shares of company stock valued at $4,511,344 over the last quarter. Company insiders own 0.54% of the company's stock.

Institutional Trading of Amrize

A number of large investors have recently made changes to their positions in AMRZ. Norges Bank bought a new stake in shares of Amrize in the 4th quarter valued at $929,333,000. Harris Associates L P bought a new stake in Amrize in the 4th quarter valued at $615,406,000. Vanguard Group Inc. lifted its position in Amrize by 41.0% in the 3rd quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company's stock valued at $1,468,460,000 after acquiring an additional 8,743,543 shares in the last quarter. Wellington Management Group LLP lifted its position in Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock valued at $561,018,000 after acquiring an additional 3,809,133 shares in the last quarter. Finally, Marshall Wace LLP lifted its position in Amrize by 865.4% in the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company's stock valued at $139,436,000 after acquiring an additional 2,590,336 shares in the last quarter.

Analyst Upgrades and Downgrades

AMRZ has been the subject of a number of research reports. Wells Fargo & Company lowered their price target on shares of Amrize from $66.00 to $65.00 and set an "overweight" rating for the company in a report on Wednesday, April 15th. Truist Financial raised their price target on shares of Amrize from $60.00 to $75.00 and gave the company a "buy" rating in a report on Friday, February 20th. Royal Bank Of Canada raised their price target on shares of Amrize from $60.00 to $61.00 and gave the company a "sector perform" rating in a report on Thursday, February 19th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Amrize in a report on Monday, February 23rd. Finally, Berenberg Bank set a $70.00 price objective on shares of Amrize in a research note on Thursday, February 19th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $64.07.

Read Our Latest Analysis on AMRZ

Amrize Price Performance

AMRZ opened at $53.72 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37. Amrize has a 12 month low of $44.12 and a 12 month high of $65.94. The company has a fifty day simple moving average of $57.86 and a 200 day simple moving average of $54.87. The stock has a market cap of $29.71 billion and a P/E ratio of 25.70.

Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.88%. The firm had revenue of $2.18 billion during the quarter. Amrize's revenue was up 4.7% on a year-over-year basis. On average, research analysts expect that Amrize will post 2.76 EPS for the current year.

Amrize Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be given a $0.11 dividend. The ex-dividend date is Tuesday, May 12th.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines